CoChat
Sign Up
Cited by 456Treatment of Major DepressionPain Management and Placebo EffectAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database

Khan, Arif, Leventhal, Robyn M., Khan, Shirin R., Brown, Walter A.·2002·Journal of Clinical Psychopharmacology
DOI 10.1097/00004714-200202000-00007
Open this paper in CoChat — free account

Abstract

Some studies suggest that more severely ill patients with depression respond well to antidepressants and poorly to placebo, whereas those who are mildly ill respond equally well to antidepressants and placebo. This notion has implications for the design of clinical trials. To further assess and substantiate these putative predictors of antidepressant and placebo response, we assessed the Food and Drug Administration database of 45 phase II and III antidepressant clinical trials. The frequency of statistically significant differences between antidepressants and placebo was higher in the trials that included patients with more severe depression. In the antidepressant-treated groups, the magnitude of symptom reduction was significantly related to mean initial Hamilton Rating Scale for Depression (HAM-D) score; the higher the mean initial HAM-D score, the larger the change. With placebo treatment, however, the higher the mean initial HAM-D score, the smaller the change. Early discontinuation was more frequent among patients whose mean initial HAM-D scores were higher. These data may help inform the design of future antidepressant clinical trials.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-200202000-00007

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 6

  1. Klerman, 1965, Pharmacol Rev, 17, 101
  2. Morris, 1974, Arch Gen Psychiatry, 31, 33
  3. Brown, 1988, Psychopharmacol Bull, 24, 14
  4. Galinowski, 1991, Encephale, 17, 387
  5. Peselow, 1989, Br J Psychiatry, 155, 667
  6. Wilcox, 1992, Psychopharmacol Bull, 28, 157

Cited by

Sorted by citations

See all 456

Related

Metadata

Authors
Khan, A., Leventhal, R. M., Khan, S. R., & Brown, W. A.
Affiliations
  • Northwest Clinical Research Center (US)
  • Tufts University (US)
Corresponding author
  • Khan, Arif
  • Leventhal, Robyn M.
  • Khan, Shirin R.
ORCID
Venue
Journal of Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2002-02
Volume
22
Issue
1
Pages
40-45
ISSN
0271-0749 (ISSN-L)
DOI
10.1097/00004714-200202000-00007
OpenAlex
W2094608167
Cited by
456
References
21
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 28 · 2018: 18 · 2017: 21 · 2016: 18 · 2015: 33 · 2014: 41 · 2013: 20 · 2012: 27
FWCI
10.78
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
depression severity, antidepressant response, placebo response, antidepressant clinical trials, trial design, Hamilton Depression Rating Scale, treatment discontinuation, symptom relief
MeSH terms
Adolescent, Adult, Antidepressive Agents, Depressive Disorder, Double-Blind Method, Humans, Personality Inventory, United States, United States Food and Drug Administration, Placebo Effect, Randomized Controlled Trials as Topic, Databases, Factual, Treatment Outcome, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review